Hoth is great I love ATAT's and how sick the og map is in game
Indicators and Patterns
Monthly TF
- Descending wedge being tested with ATH volume
Weekly TF
- 21EMA used as support for the first time
- SMA50 being tested
- Year-long squeeze reversed
- MacZ MA passing zero line
Daily TF
- Cup & Handle formed
- EMA21 has crossed all SMA's
- Bear consolidation gave room from oversold territory
- Bull cross on MACZVWAP
- High Volatile to Low Volatile pump/dump downtrend that leads to huge volume pump with gap that fills right away. Moving averages are now squeezing
2hr TF
- MA's at squoze levels (chronological to top down)
Fundamentals
- "Hoth Therapeutics filed a provisional patent application" - SEC Feb.23 (patent lasts 12 months)
- Leading drug for eczema research Approaching Phase II of clinical
- "Hoth Therapeutics Announces Licensing Agreement and Collaboration with U.S. Army Medical Research and Development Command" - SEC Jan.8
- Institutional ownership has increase by 6x since June
- 360k shares bought by institutions (
1M) since beginning of 2021
- Vanguard and Fidelity own about 65k shares
- Insider ownership - 52%
- Institutional ownership - 15%
- Float - 33%
- Short Float 7%
- Short interest .13
Verdict - $5 PT by EOM for March
Monthly TF
- Descending wedge being tested with ATH volume
Weekly TF
- 21EMA used as support for the first time
- SMA50 being tested
- Year-long squeeze reversed
- MacZ MA passing zero line
Daily TF
- Cup & Handle formed
- EMA21 has crossed all SMA's
- Bear consolidation gave room from oversold territory
- Bull cross on MACZVWAP
- High Volatile to Low Volatile pump/dump downtrend that leads to huge volume pump with gap that fills right away. Moving averages are now squeezing
2hr TF
- MA's at squoze levels (chronological to top down)
Fundamentals
- "Hoth Therapeutics filed a provisional patent application" - SEC Feb.23 (patent lasts 12 months)
- Leading drug for eczema research Approaching Phase II of clinical
- "Hoth Therapeutics Announces Licensing Agreement and Collaboration with U.S. Army Medical Research and Development Command" - SEC Jan.8
- Institutional ownership has increase by 6x since June
- 360k shares bought by institutions (
1M) since beginning of 2021- Vanguard and Fidelity own about 65k shares
- Insider ownership - 52%
- Institutional ownership - 15%
- Float - 33%
- Short Float 7%
- Short interest .13
Verdict - $5 PT by EOM for March
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.